HAE Still Drawing Attention From Drugmakers

(MedPage Today) -- NEW ORLEANS--Although still technically an orphan disease, hereditary angioedema (HAE) remains a popular focus for drug developers despite a half-dozen products already approved in the U.S.
That was on full display at the...